INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

BSEMBioStem Technologies, Inc.

CIK 0001658678

EDGAR filingsOpen in network
Disclosed transactions12
Buys / sells0 / 0
Max Insider Score31
Connections8with evidence

BSEM · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SD
Sonenreich Steven DDirector
BSEMBioStem Technologies, Inc.
Option exercise
M—
7,671 sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Sonenreich Steven DDirector · Aug 28, 2026
  • ← Insider ofevidence
    Warrington Kenneth Howard JrDirector · Aug 28, 2026
  • ← Insider ofevidence
    Lesser Hannaway RaynaDirector · Aug 28, 2026
  • ← Insider ofevidence
9
UJ
Ungrodt JodiDirector
BSEMBioStem Technologies, Inc.
Option exercise
M
—
5,647 sh
Aug 27, 2026
Aug 28, 2026
traded Aug 27, 2026
+1d
SEC FORM 4

Evidence

9
LR
Lesser Hannaway RaynaDirector
BSEMBioStem Technologies, Inc.
Option exercise
M—
7,671 sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC FORM 4

Evidence

9
LR
Lesser Hannaway RaynaDirector
BSEMBioStem Technologies, Inc.
Option exercise
M—
7,671 sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC FORM 4

Evidence

9
SD
Sonenreich Steven DDirector
BSEMBioStem Technologies, Inc.
Option exercise
M—
7,671 sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC FORM 4

Evidence

21
UJ
Ungrodt JodiDirector
BSEMBioStem Technologies, Inc.
Option exercise
M—
5,647 sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC FORM 4

Evidence

13
WH
Warrington Kenneth Howard JrDirector
BSEMBioStem Technologies, Inc.
Option exercise
M—
5,094 sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC FORM 4

Evidence

9
WH
Warrington Kenneth Howard JrDirector
BSEMBioStem Technologies, Inc.
Option exercise
M—
5,094 sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC FORM 4

Evidence

19
FA
Fortunato Michael AChief Accounting Officer
BSEMBioStem Technologies, Inc.
Option exercise
M—
970 sh
Aug 9, 2026Aug 20, 2026
traded Aug 9, 2026
+11dSEC FORM 4

Evidence

23
FA
Fortunato Michael AChief Accounting Officer
BSEMBioStem Technologies, Inc.
Option exercise
M—
970 sh
Aug 9, 2026Aug 20, 2026
traded Aug 9, 2026
+11dSEC FORM 4

Evidence

27
PB
Poe BrandonChief Financial Officer
BSEMBioStem Technologies, Inc.
Option exercise
M—
10.6K sh
Aug 11, 2026Aug 20, 2026
traded Aug 11, 2026
+9dSEC FORM 4

Evidence

31
PB
Poe BrandonChief Financial Officer
BSEMBioStem Technologies, Inc.
Option exercise
M—
10.6K sh
Aug 11, 2026Aug 20, 2026
traded Aug 11, 2026
+9dSEC FORM 4

Evidence

Ungrodt Jodi
Director · Aug 28, 2026
  • ← Lobbied forevidence
    BALLARD PARTNERSLDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Insider ofevidence
    Poe BrandonChief Financial Officer · Aug 20, 2026
  • ← Insider ofevidence
    Fortunato Michael AChief Accounting Officer · Aug 20, 2026

    • Lobbying

    $180K reported · de-duplicated
    2026 Q2 $60K via firms2026 Q1 $120K via firms
    • BALLARD PARTNERS$60K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid
    • BALLARD PARTNERS$120K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.